Results 151 to 160 of about 13,727 (197)

Sacubitril/valsartan improves nocturia in hypertensive patients: a pilot study. [PDF]

Transl Androl Urol
Kitta T, Kakizaki H, Kihara H.
europepmc   +1 more source

A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Wang S, Lai J, Chen J, Luo Q, Yi W, Lai Y.   +5 more
europepmc   +1 more source

Impact of treatment strategies incorporating sacubitril/valsartan on achievement of guideline-recommended blood pressure targets and representative safety outcomes. [PDF]

Hypertens Res
Katsuya T, Nakatsu F, Eguchi S, Nakamura Y, Matsukawa M, Iekushi K, Hiramitsu S.   +6 more
europepmc   +1 more source

Patient-Centered Outcomes in Heart Failure Pharmacotherapy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

JACC Adv
Kido K, Hashiguchi M, Guglin M.
europepmc   +1 more source

Effects of Vericiguat on the Mitochondrial Function and Clinical Outcomes in CRT Nonresponders Patients. [PDF]

JACC Adv
Sardu C, D'Onofrio N, Fumagalli C, Balestrieri ML, Landolfi A, La Marca C, Giordano V, Donisi I, Rambaldi P, Gatta G, Cappabianca S, Sasso FC, Barbieri M, Paolisso G, Marfella R.   +14 more
europepmc   +1 more source

A propensity score-matched retrospective study on sacubitril/valsartan use and 6-month readmission rates in patients with acute heart failure. [PDF]

PeerJ
Zhang L, Chen Q, Ren G.
europepmc   +1 more source

Early sacubitril/valsartan use associated with reduced atrial fibrillation risk in patients with acute myocardial infarction complicated by mitral regurgitation: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Yin H, Zhou Y, Zhou Y, Ren L, Ma L.
europepmc   +1 more source

A sensitive green HPLC-fluorescence method for simultaneous analysis of sacubitril and valsartan in pure forms, pharmaceutical dosage form and human plasma. [PDF]

Sci Rep
Kormod LA, Hegazy MA, Kessiba AM.
europepmc   +1 more source

Improvement in Right Ventricular Function and Pulmonary Pressures in Patients With Severe Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction Treated With Sacubitril-Valsartan. [PDF]

Pulm Circ
Abofrekha B, Jdaidani J, Shadi M, Sanayeh EB, Agarwal A, Zaidan N, Rojas-Marte GR.   +6 more
europepmc   +1 more source

Innovative diagnostische und therapeutische Optionen bei der linksventrikulären kardialen Hypertrophie [PDF]

, 2018
Beetz, Nick Lasse
core